Does Baker have shares in Pfizer?

As our “top” epidemiologist says brace yourself for booster upon booster upon booster, Pfizer is warning its shareholders that they are at risk of share price volatility due to the outcome of the release of their clinical trial information.

Brace for unfavourable clinical safety data.

Interesting that this is the first time they have warned of this threat to their shareholders and is timely given that the release of all the safety info documentation from the FDA has been reduced from 75 years to 10 months. 55,000 documents to be released on March 1, 2022.

We may get a glimpse of just how safe and effective it is.

But nothing to see there folks, the government epidemiologists will just talk everyone to get boosted.

Soon we will have hit songs


Boostin to the east, boostin to the west, boostin with the girl I like best.

Loading spinner
Would love your thoughts, please comment.x